World News: Canada has temporarily suspended vaccinating people with AstraZeneca vaccine for people under 55 as there are warnings of occasional and potential blood clots when injected. The National Advisory Committee for Immunisation has directed its provinces to stop vaccination for all those citizens under 55, on Monday.
Dr. Shelley Deeks, Vice Chair of the NACI, told that there is a “substantial uncertainty” in the usage of the vaccine. Despite there is no increased risk of blood clots from the vaccination, in Europe a particular discovery regarding the vaccine shows that a rare but serious side effects were observed on young women, from the usage of vaccine, says Dr. Joss Reimer, part of the Manitoba Vaccine Implementation Task Force.
He also said that until further clearance from tests on the vaccine, people under 55 will kept away from vaccination for a while. The incident of this occasional blood clot happens only one in 1,00,000 or 10,00,000 cases. And, the blood clot typically happens within 4-20 days of receiving the first dose of vaccine.
As far as now, none of the incidents of blood clots have reported from Canada. Only those of ages 60 and above have received vaccinations till now and field doctors have not reported anything unusual with those who received vaccinations. AstraZeneca’s COVAXIN is having a hard time being trusted to be a safe and effective one in Europe and North America.
Several European nations have called for suspension of the vaccine over questions on its effectiveness and safety. Due to this, Europe is seeing a very slow vaccination program that is not going smooth at the moment. Even Canada had considered to issue the vaccine vials with a warning label attached, in Canada.
U.S will be supplying 1.5 million doses of AstraZeneca’s vaccine to Canada. Till now Canada has made deals with seven vaccine companies. With 76 million doses of Pfizer, 44 million doses of Moderna and 20 million of AstraZeneca vaccines, Canada will procure enough numbers to give 10 doses of each of the 38 million people in Canada.
Like Europe, vaccination progress in Canada is also slow as they cannot produce their own vaccines and depend on the global supply chains for the vaccines.